JW Life Science Corp
KRX:234080
JW Life Science Corp
KRX:234080
Price:
13 180
KRW
1.54%
Market Closed
Market Cap:
₩208.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
JW Life Science Corp
KRX:234080
|
KR |
Balance Sheet
Balance Sheet Decomposition
JW Life Science Corp
JW Life Science Corp
Balance Sheet Decomposition is not available for
JW Life Science Corp
JW Life Science Corp
Balance Sheet
JW Life Science Corp
JW Life Science Corp
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
64
|
864
|
384
|
300
|
12 777
|
9 861
|
2 592
|
0
|
1
|
20 222
|
7 511
|
|
| Cash |
3
|
1
|
2
|
1
|
2
|
1
|
2
|
0
|
1
|
20 222
|
7 511
|
|
| Cash Equivalents |
61
|
863
|
382
|
299
|
12 775
|
9 860
|
2 590
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
10
|
10
|
0
|
0
|
0
|
0
|
0
|
155
|
24 953
|
8 152
|
2 110
|
|
| Total Receivables |
24 024
|
20 588
|
32 984
|
42 263
|
30 354
|
34 088
|
36 578
|
37 198
|
53 772
|
55 731
|
59 862
|
|
| Accounts Receivables |
21 660
|
20 152
|
31 548
|
41 130
|
30 084
|
33 892
|
34 716
|
32 141
|
53 318
|
55 388
|
42 667
|
|
| Other Receivables |
2 364
|
436
|
1 436
|
1 133
|
270
|
196
|
1 862
|
5 058
|
454
|
343
|
17 196
|
|
| Inventory |
12 301
|
14 780
|
13 826
|
12 151
|
14 670
|
15 777
|
16 786
|
21 077
|
22 067
|
23 399
|
35 448
|
|
| Other Current Assets |
305
|
2 578
|
58
|
246
|
126
|
130
|
540
|
1 077
|
297
|
330
|
732
|
|
| Total Current Assets |
36 704
|
38 821
|
47 253
|
54 960
|
57 926
|
59 856
|
56 496
|
64 430
|
105 008
|
107 834
|
105 664
|
|
| PP&E Net |
118 332
|
133 059
|
136 794
|
135 243
|
132 753
|
131 690
|
135 423
|
137 145
|
131 555
|
124 577
|
132 051
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
135 423
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
602
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
4 244
|
3 321
|
3 359
|
3 341
|
5 330
|
4 980
|
4 810
|
4 361
|
3 583
|
3 175
|
3 469
|
|
| Goodwill |
951
|
951
|
951
|
951
|
951
|
951
|
951
|
951
|
953
|
951
|
74 266
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
651
|
494
|
666
|
|
| Long-Term Investments |
3 068
|
3 225
|
3 381
|
3 438
|
3 368
|
3 363
|
19 452
|
11 731
|
7 164
|
13 169
|
3 296
|
|
| Other Long-Term Assets |
544
|
504
|
507
|
600
|
531
|
565
|
910
|
849
|
4 029
|
5 637
|
5 911
|
|
| Other Assets |
951
|
951
|
951
|
951
|
951
|
951
|
951
|
951
|
953
|
951
|
74 266
|
|
| Total Assets |
163 842
N/A
|
179 881
+10%
|
192 244
+7%
|
198 532
+3%
|
200 860
+1%
|
201 404
+0%
|
218 041
+8%
|
219 467
+1%
|
252 942
+15%
|
255 836
+1%
|
325 324
+27%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
6 631
|
6 564
|
10 015
|
11 781
|
11 595
|
11 263
|
10 714
|
12 496
|
15 118
|
18 740
|
19 617
|
|
| Accrued Liabilities |
2 711
|
1 132
|
1 979
|
2 005
|
2 108
|
1 910
|
1 451
|
1 600
|
2 461
|
2 572
|
2 438
|
|
| Short-Term Debt |
49 350
|
59 200
|
54 700
|
39 950
|
39 600
|
34 040
|
32 000
|
44 350
|
21 700
|
15 700
|
35 644
|
|
| Current Portion of Long-Term Debt |
9 977
|
0
|
0
|
5 000
|
5 000
|
5 020
|
2 965
|
496
|
15 448
|
30 398
|
519
|
|
| Other Current Liabilities |
8 536
|
15 386
|
14 447
|
15 518
|
14 824
|
14 638
|
22 138
|
24 961
|
25 316
|
26 849
|
21 961
|
|
| Total Current Liabilities |
77 206
|
82 282
|
81 142
|
74 254
|
73 127
|
66 871
|
69 268
|
83 902
|
80 044
|
94 259
|
80 179
|
|
| Long-Term Debt |
2 620
|
8 414
|
14 035
|
15 429
|
10 430
|
5 467
|
1 573
|
1 642
|
30 047
|
215
|
33 075
|
|
| Deferred Income Tax |
4 379
|
4 843
|
4 672
|
4 753
|
4 439
|
4 897
|
2 186
|
2 243
|
2 011
|
1 828
|
7 406
|
|
| Other Liabilities |
2 696
|
1 509
|
2 093
|
1 995
|
3 607
|
1 553
|
12 953
|
188
|
508
|
142
|
4 219
|
|
| Total Liabilities |
86 901
N/A
|
97 049
+12%
|
101 942
+5%
|
96 431
-5%
|
91 602
-5%
|
78 788
-14%
|
85 980
+9%
|
87 975
+2%
|
112 610
+28%
|
96 443
-14%
|
124 879
+29%
|
|
| Equity | ||||||||||||
| Common Stock |
39 586
|
39 586
|
39 586
|
39 586
|
39 586
|
39 586
|
39 586
|
39 586
|
39 586
|
39 586
|
39 586
|
|
| Retained Earnings |
9 020
|
14 910
|
22 380
|
34 180
|
41 336
|
54 694
|
64 139
|
70 319
|
79 160
|
98 220
|
132 422
|
|
| Additional Paid In Capital |
28 335
|
28 335
|
28 335
|
28 335
|
28 335
|
28 335
|
28 335
|
28 335
|
28 335
|
28 335
|
28 335
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6 749
|
6 749
|
6 749
|
6 749
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6 850
|
|
| Total Equity |
76 941
N/A
|
82 832
+8%
|
90 302
+9%
|
102 101
+13%
|
109 257
+7%
|
122 615
+12%
|
132 061
+8%
|
131 492
0%
|
140 332
+7%
|
159 393
+14%
|
200 445
+26%
|
|
| Total Liabilities & Equity |
163 842
N/A
|
179 881
+10%
|
192 244
+7%
|
198 532
+3%
|
200 860
+1%
|
201 404
+0%
|
218 041
+8%
|
219 467
+1%
|
252 942
+15%
|
255 836
+1%
|
325 324
+27%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
16
|
16
|
16
|
16
|
16
|
16
|
16
|
15
|
15
|
15
|
15
|
|
Switch to:
Switch to:
See Also
Discover More
